Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
51.93
1.79 (3.57%)
At close: Aug 15, 2025, 2:46 PM

Anbio Biotechnology Class A Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022
Cash & Equivalents
11.76M 10.31M 9.69M 10.56M 7.1M
Short-Term Investments
n/a n/a n/a n/a 1.57M
Long-Term Investments
n/a n/a n/a n/a n/a
Other Long-Term Assets
387.44K 176.99K 62.14K 276.8K 2.99K
Receivables
1.06M 4.62M 1.88M 3.58K 3.58K
Inventory
n/a n/a n/a n/a 353.87K
Other Current Assets
n/a n/a n/a n/a n/a
Total Current Assets
18.53M 18.77M 15.75M 15.15M 13.94M
Property-Plant & Equipment
n/a n/a n/a 3.27K 12.06K
Goodwill & Intangibles
n/a n/a n/a n/a n/a
Total Long-Term Assets
387.44K 176.99K 62.14K 280.07K 15.05K
Total Assets
18.92M 18.94M 15.81M 15.43M 13.96M
Account Payables
1.63M 478.96K 827.15K 1.31M 1.41M
Deferred Revenue
n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a n/a
Total Current Liabilities
1.73M 527.75K 993.06K 1.34M 1.41M
Long-Term Debt
n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a
Total Liabilities
1.73M 527.75K 993.06K 1.34M 1.41M
Total Debt
n/a n/a n/a n/a n/a
Common Stock
14.23K 14.23K 14.23K 14.23K n/a
Retained Earnings
17.17M 18.4M 14.8M 14.07M 12.55M
Comprehensive Income
n/a n/a n/a n/a n/a
Shareholders Equity
17.19M 18.42M 14.82M 14.09M 12.55M
Total Investments
n/a n/a n/a n/a 1.57M